FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of pharmaceutics and represents composition for reducing injury caused by ultraviolet radiation, which includes one or more compounds selected from the group consisting of D-methionine and its salts.
EFFECT: invention provides creation of stable and safe composition, which can be applied daily.
10 cl, 37 ex, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR RELIEVING ULTRAVIOLET INJURIES | 2010 |
|
RU2519206C2 |
| COMPOSITION FOR SKIN PROTECTION FROM EXPOSURE TO HARMFUL SUBSTANCES, LIGHT AND STRESS | 2021 |
|
RU2792212C1 |
| COMPOSITION FOR STIMULATION OF PRODUCTION OF LAMININ-332 | 2010 |
|
RU2581916C2 |
| COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
| PEPTIDE PROTECTION AGAINST ULTRAVIOLET LIGHT TOXICITY | 2010 |
|
RU2565535C2 |
| PTEROSTILBENE (PTER) APPLICABLE IN PREVENTING AND/OR TREATING SKIN DISEASES, INJURIES AND TRAUMAS | 2010 |
|
RU2578031C2 |
| ANTIOXIDANT COMPOSITION | 2010 |
|
RU2535099C2 |
| SKIN REPAIR COMPOSITIONS CONTAINING CIRCADIAN GENE ACTIVATORS AND SYNERGISTIC COMBINATION OF sirt1 GENE ACTIVATORS | 2010 |
|
RU2494756C1 |
| RECOVERED PEPTIDE FOR ENHANCING WOUND HEALING ACTIVITY OF KERATINOCYTES, COMPOSITION FOR WOUND HEALING IN MAMMAL AND DRUG APPLIED IN WOUND HEALING IN MAMMAL | 2007 |
|
RU2458069C2 |
| TYROSINE INHIBITORS WITH IMMUNOSUPPRESSIVE ACTIVITY IN HUMAN NEONATAL KERATINOCYTE PROGENOUS CELLS | 2020 |
|
RU2809007C2 |
